# BIOMARIN PHARMACEUTICAL INC (BMRN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from BIOMARIN PHARMACEUTICAL INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BMRN/mda/fy2025/): filed 2026-02-26; accession 0001048477-26-000004 (https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BMRN/mda/fy2024/): filed 2025-02-24; accession 0001048477-25-000007 (https://www.sec.gov/Archives/edgar/data/1048477/000104847725000007/bmrn-20241231.htm)
- [FY 2023 MD&A](/company/BMRN/mda/fy2023/): filed 2024-02-26; accession 0001048477-24-000016 (https://www.sec.gov/Archives/edgar/data/1048477/000104847724000016/bmrn-20231231.htm)
- [FY 2022 MD&A](/company/BMRN/mda/fy2022/): filed 2023-02-27; accession 0001048477-23-000009 (https://www.sec.gov/Archives/edgar/data/1048477/000104847723000009/bmrn-20221231.htm)
- [FY 2021 MD&A](/company/BMRN/mda/fy2021/): filed 2022-02-25; accession 0001048477-22-000012 (https://www.sec.gov/Archives/edgar/data/1048477/000104847722000012/bmrn-20211231.htm)

Back to /company/BMRN/